Smurf1-KO Mouse
Common Name
Smurf1-KO
제품 ID
S-KO-14749
Backgroud
C57BL/6NCya
품종 계통계통 ID
KOCMP-75788-Smurf1-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Smurf1-KO Mouse (카탈로그 번호 S-KO-14749)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Smurf1-KO
품종 계통계통 ID
KOCMP-75788-Smurf1-B6N-VA
유전자명
제품 ID
S-KO-14749
유전자 별칭
mKIAA1625, 4930431E10Rik
배경
C57BL/6NCya
유전자 공식 전체 명칭
SMAD specific E3 ubiquitin protein ligase 1
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 5
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000085684
NCBI 전사체 ID
NM_001038627
타겟 영역
Exon 2~6
유효 영역 크기
~4.6 kb
유전자 연구 개요
Smurf1, short for SMAD specific E3 ubiquitin protein ligase 1, is a HECT-type E3 ubiquitin ligase. It is involved in multiple biological pathways, such as the bone morphogenetic protein pathway, non-canonical Wnt pathway, and mitogen-activated protein kinase pathway. Smurf1 plays crucial roles in cell growth, morphogenesis, migration, polarity, and autophagy, and is related to physiological manifestations like age-dependent bone formation deficiency and tumor cell invasion [8]. Gene knockout (KO) and conditional knockout (CKO) mouse models have been valuable for studying its functions.
In cancer, Smurf1 overexpression is linked to poor prognosis in various cancers. For example, in glioblastoma, colon cancer, and clear cell renal cell carcinoma, it acts as a tumor promoter by ubiquitinating and degrading tumor-suppressing proteins. In KRAS-mutated colorectal cancer, Smurf1-mediated PDK1 neddylation activates the PI3K-Akt signaling pathway and promotes tumorigenesis, and Smurf1 deficiency reduces tumor formation in a genetic mouse model [1,4]. In autophagy, Smurf1 controls TFEB nuclear import for lysosomal biogenesis. Blocking Smurf1 prevents TFEB nuclear translocation in response to lysosomal damage [2]. In hepatocellular carcinoma, Smurf1-mediated UVRAG ubiquitination promotes autophagosome maturation and inhibits tumor growth [3]. In glioblastoma, Smurf1 protects against endoplasmic reticulum stress by degrading KEAP1 to activate the NRF2 antioxidant pathway, and its knockdown reduces cell proliferation and growth in xenografts [5]. In lupus nephritis, Smurf1 upregulation activates the cGAS/STING/IFN-1 signal axis by ubiquitinating YY1, accelerating disease progression, and Smurf1 knockdown inhibits LN progression in vivo [7]. In ameloblasts, Smurf1 regulates polarization through ubiquitination-mediated degradation of RhoA, and local knockdown in rat lower incisor ameloblasts leads to polarity loss and enamel disorders [6]. In dry age-related macular degeneration, inhibiting Smurf1 in a mouse model alleviates acute retina injury, and in an in vitro oxidative stress model, it has an anti-epithelial mesenchymal transition function [9].
In summary, Smurf1 is a key E3 ubiquitin ligase involved in numerous biological functions, especially in processes related to cancer, autophagy, and cell polarity. Studies using KO/CKO mouse models have significantly enhanced our understanding of its role in these disease areas, providing potential therapeutic targets for various diseases such as cancer, lupus nephritis, and age-related macular degeneration.
References:
1. Xia, Qin, Li, Yang, Han, Da, Dong, Lei. 2020. SMURF1, a promoter of tumor cell progression? In Cancer gene therapy, 28, 551-565. doi:10.1038/s41417-020-00255-8. https://pubmed.ncbi.nlm.nih.gov/33204002/
2. Xia, Qin, Zheng, Hanfei, Li, Yang, Zhang, Lingqiang, Dong, Lei. 2023. SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis. In Autophagy, 20, 735-751. doi:10.1080/15548627.2023.2267413. https://pubmed.ncbi.nlm.nih.gov/37909662/
3. Feng, Xing, Jia, Yanyan, Zhang, Yuyu, Qiu, Xingfeng, Zhang, Zhiyong. 2019. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. In Autophagy, 15, 1130-1149. doi:10.1080/15548627.2019.1570063. https://pubmed.ncbi.nlm.nih.gov/30686098/
4. Peng, Zhiqiang, Fang, Wei, Wu, Bo, Cui, Chun-Ping, Zhang, Lingqiang. 2024. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. In Nature chemical biology, 21, 59-70. doi:10.1038/s41589-024-01683-5. https://pubmed.ncbi.nlm.nih.gov/39039255/
5. Dong, Lei, Xu, Mengchuan, Li, Yang, Zhou, Liying, Xia, Qin. 2023. SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. In Cell death & disease, 14, 361. doi:10.1038/s41419-023-05873-2. https://pubmed.ncbi.nlm.nih.gov/37316499/
6. Niu, Haoman, Bi, Fei, Zhao, Wenjun, Guo, Weihua, Chen, Yu. 2022. Smurf1 regulates ameloblast polarization by ubiquitination-mediated degradation of RhoA. In Cell proliferation, 56, e13387. doi:10.1111/cpr.13387. https://pubmed.ncbi.nlm.nih.gov/36579844/
7. Li, Xiaoyan, Tao, Sisi, Xu, Zhiquan, Xiang, Wei, He, Xiaojie. 2023. SMURF1 activates the cGAS/STING/IFN-1 signal axis by mediating YY1 ubiquitination to accelerate the progression of lupus nephritis. In Autoimmunity, 56, 2281235. doi:10.1080/08916934.2023.2281235. https://pubmed.ncbi.nlm.nih.gov/37994046/
8. Cao, Yu, Zhang, Lingqiang. 2012. A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks. In Cellular and molecular life sciences : CMLS, 70, 2305-17. doi:10.1007/s00018-012-1170-7. https://pubmed.ncbi.nlm.nih.gov/23007848/
9. Li, Duo, Wei, Ting-Ting, Cai, Jiping, Yao, Yong, Zhu, Lingpeng. 2023. Smurf1: A possible therapeutic target in dry age-related macular degeneration. In Experimental eye research, 233, 109549. doi:10.1016/j.exer.2023.109549. https://pubmed.ncbi.nlm.nih.gov/37348673/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
